source
- Tiziana Life Sciences CEO Ivor Elrifi boosts stake, buying 321,423 shares at $1 eachTiziana Life Sciences announced that its chief executive officer, Ivor Elrifi, purchased 321,423 common shares of the company on NASDAQ at $1.00 per share. The purchase raises his total holding to…
- Medicare advances ACCESS pilot but leaves patients unaware of participating providersSTAT's Health Tech newsletter reports that Medicare is promoting its ACCESS chronic‑care pilot, yet patients cannot see which providers are offering the program. A one‑month progress check highlig…